Travere Therapeutics, Inc.
US ˙ NasdaqGM ˙ US89422G1076

SecurityTVTX / Travere Therapeutics, Inc.
InstitutionOak Ridge Investments Llc
Latest Disclosed Ownership67,323 shares
Latest Disclosed Value $ 2,000,166
Oak Ridge Investments Llc reports 1.42% increase in ownership of TVTX / Travere Therapeutics, Inc.

On April 30, 2026 - Oak Ridge Investments Llc filed a 13F-HR form disclosing ownership of 67,323 shares of Travere Therapeutics, Inc. (US:TVTX) valued at $2,000,166 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 23, 2026 disclosing 66,383 shares of Travere Therapeutics, Inc.. This represents a change in shares of 1.42% during the quarter. The current value of the position is $3,043,000 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-30 2026-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 67,323 940 1.42 2,000 -21.14 0.1323
2026-01-23 2025-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 66,383 -1,849 -2.71 2,536 55.58 0.1537
2025-10-29 2025-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 68,232 16,755 32.55 1,631 114.19 0.1054
2025-07-25 2025-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 51,477 -2,593 -4.80 762 -21.38 0.0546
2025-05-13 2025-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 54,070 1,471 2.80 969 5.68 0.0806
2025-01-15 2024-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 52,599 -2,740 -4.95 916 18.35 0.0719
2024-10-28 2024-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 55,339 -2,245 -3.90 774 63.64 0.0675
2024-10-28 2024-06-30 13F/A-1 TRAVERE THERAPEUTICS COM 89422G107 57,584 -8,342 -12.65 473 -6.89 0.0451
2024-07-16 2024-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 57,584 -8,342 473 0.0451
2024-05-01 2024-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 65,926 7,744 13.31 508 -2.87 0.0513
2024-01-16 2023-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 58,182 -16,132 -21.71 523 -21.23 0.0602
2023-10-30 2023-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 74,314 -2,301 -3.00 664 -43.54 0.0848
2023-08-07 2023-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 76,615 -3,435 -4.29 1,177 -34.67 0.1451
2023-04-14 2023-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 80,050 -3,927 -4.68 1,800 1.93 0.2437
2023-01-24 2022-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 83,977 -3,091 -3.55 1,766 -17.67 0.2630
2022-11-08 2022-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 87,068 -198 -0.23 2,145 1.47 0.3251
2022-07-28 2022-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 87,266 -5,387 -5.81 2,114 -11.47 0.3076
2022-04-22 2022-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 92,653 -56,424 -37.85 2,388 -48.39 0.2653
2022-02-01 2021-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 149,077 -2,762 -1.82 4,627 25.67 0.3907
2021-11-05 2021-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 151,839 -3,129 -2.02 3,682 62.85 0.3243
2021-07-30 2021-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 154,968 -8,403 -5.14 2,261 -44.57 0.1975
2021-05-12 2021-03-31 13F/A-1 TRAVERE THERAPEUTICS COM 89422G107 163,371 41,295 33.83 4,079 22.60 0.3798
2021-05-04 2021-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 1,323,149 1,201,073 33,039 0.3012
2021-02-03 2020-12-31 13F TRAVERE THERAPEUTICS COM COM 89422G107 122,076 -31,777 -20.65 3,327 17.15 0.2931
2020-11-12 2020-09-30 13F RETROPHIN INC COM COM 761299106 153,853 -9,951 -6.07 2,840 -15.05 0.2211
2020-08-05 2020-06-30 13F RETROPHIN INC COM COM 761299106 163,804 -18,313 -10.06 3,343 25.82 0.2805
2020-05-13 2020-03-31 13F RETROPHIN INC COM COM 761299106 182,117 1,648 0.91 2,657 3.67 0.2720
2020-02-05 2019-12-31 13F RETROPHIN INC COM COM 761299106 180,469 -35,825 -16.56 2,563 2.23 0.1881
2019-11-07 2019-09-30 13F RETROPHIN INC COM COM 761299106 216,294 -28,987 -11.82 2,507 -49.13 0.1886
2019-08-14 2019-06-30 13F RETROPHIN INC COM COM 761299106 245,281 -18,315 -6.95 4,928 -17.38 0.3406
2019-05-09 2019-03-31 13F RETROPHIN INC COM COM 761299106 263,596 -17,523 -6.23 5,965 -6.24 0.3793
2019-02-11 2018-12-31 13F RETROPHIN INC COM COM 761299106 281,119 -13,723 -4.65 6,362 -24.90 0.4579
2018-11-07 2018-09-30 13F RETROPHIN INC COM COM 761299106 294,842 -35,012 -10.61 8,471 -5.79 0.4677
2018-08-13 2018-06-30 13F RETROPHIN INC COM COM 761299106 329,854 -29,691 -8.26 8,992 11.85 0.5096
2018-05-14 2018-03-31 13F RETROPHIN INC COM COM 761299106 359,545 -132,361 -26.91 8,039 -22.43 0.4460
2018-02-13 2017-12-31 13F RETROPHIN INC COM COM 761299106 491,906 -247,556 -33.48 10,364 -43.69 0.4946
2017-11-07 2017-09-30 13F RETROPHIN INC COM COM 761299106 739,462 -283,409 -27.71 18,405 -7.20 0.7477
2017-08-10 2017-06-30 13F RETROPHIN INC COM COM 761299106 1,022,871 503,428 96.92 19,833 106.83 0.6327
2017-05-15 2017-03-31 13F RETROPHIN COM 761299106 519,443 -93,683 -15.28 9,589 -17.38 0.3220
2017-02-13 2016-12-31 13F RETROPHIN COM 761299106 613,126 613,126 11,606 0.3762
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.